NAUT · Nautilus Biotechnology, Inc. · Exempt Offerings
$2.31
-0.02 (-0.65%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$295.50M
Shares
127.37M
Volume · Nov 16
1.75M
Avg daily vol (3M)
5.87M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
65 filings
54 filers
Visit website
Investor relations